Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat Hepatitis Delta Virus (HDV) and other serious rare diseases.
First-In-Class Therapies of Patients In Need
(Swipe to interact)
Advancing Pipeline for Serious Unmet Medical Needs
